摘要:
A prospective, nonrandomized, unmasked, 1-year clinical trial was performed in 2482 eyes to evaluate the safety and efficacy of laser in situ keratomileusis (LASIK) for myopia and myopic astigmatism using a new excimer laser system. The study found that LASIK was a safe and effective method for correcting myopia and myopic astigmatism in patients with sphere to −15 diopters (D) and cylinder to 5 D.